Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Change in Cash (2020 - 2025)

Roivant Sciences (ROIV) has disclosed Change in Cash for 6 consecutive years, with $241.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Cash rose 105.31% year-over-year to $241.6 million, compared with a TTM value of -$5.8 billion through Dec 2025, down 41.91%, and an annual FY2025 reading of -$3.8 billion, down 178.73% over the prior year.
  • Change in Cash was $241.6 million for Q4 2025 at Roivant Sciences, up from -$1.4 million in the prior quarter.
  • Across five years, Change in Cash topped out at $5.0 billion in Q4 2023 and bottomed at -$4.5 billion in Q4 2024.
  • Average Change in Cash over 5 years is -$408.4 million, with a median of -$133.3 million recorded in 2021.
  • The sharpest move saw Change in Cash surged 1036.84% in 2023, then crashed 13748.95% in 2024.
  • Year by year, Change in Cash stood at $84.5 million in 2021, then crashed by 731.07% to -$533.0 million in 2022, then soared by 1036.84% to $5.0 billion in 2023, then tumbled by 191.1% to -$4.5 billion in 2024, then surged by 105.31% to $241.6 million in 2025.
  • Business Quant data shows Change in Cash for ROIV at $241.6 million in Q4 2025, -$1.4 million in Q3 2025, and -$1.5 billion in Q2 2025.